• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMM
Click for more information
2.72% 47.3¢

IMMUTEP LIMITED

Market Cap $546.8M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IMM
Overnight Market report
43 44 45
08/05/24 2.6K 1.0M
08/05/24 Last post  Joe007 Comments Created with Sketch.  2.6K  Views Created with Sketch.  1.0M 
IMM
Immutep has been featured in the latest Thematic Insights Report - Download now! 		08/05/24 3 1.0K
08/05/24 Last post  ydqcau Comments Created with Sketch.  3  Views Created with Sketch.  1.0K 
IMM
Chart 		07/05/24 32 16K
07/05/24 Last post  bioqld Comments Created with Sketch.  32  Views Created with Sketch.  16K 
IMM
EFTI at 90 		07/05/24 42 14K
07/05/24 Last post  sybasedba Comments Created with Sketch.  42  Views Created with Sketch.  14K 
IMM
The elephant in the room 		07/05/24 8 4.6K
07/05/24 Last post  Billja Comments Created with Sketch.  8  Views Created with Sketch.  4.6K 
IMM
Media 		05/05/24 1 643
05/05/24 Last post  coolkiat Comments Created with Sketch.  1  Views Created with Sketch.  643 
IMM
Ann: Positive initial data in phase 2 Soft Tissue Sarcoma trial 		05/05/24 16 7.3K
05/05/24 Last post  tankhexman Comments Created with Sketch.  16  Views Created with Sketch.  7.3K 
IMM
Media
11 12 13
04/05/24 743 329K
04/05/24 Last post  ahjay Comments Created with Sketch.  743  Views Created with Sketch.  329K 

See All Discussions arrow Created with Sketch.

Timeline

Positive initial data in phase 2 Soft Tissue Sarcoma trial
02 May 09:29
 
Immutep Quarterly Activities Report and Appendix 4C
29 Apr 08:18
 
Positive preliminary topline results from TACTI-003 Cohort B
24 Apr 08:40
 
CHDR to conduct first-in-human phase 1 trial of IMP761
18 Apr 09:36
 
Positive Feedback received from Spanish Medicines Agency
17 Apr 09:10
 
Ceasing to be a substantial holder
11 Apr 18:30
 
View More arrow Created with Sketch.

Featured News

MTL Mantle Minerals to kick off drilling at Mt Berghaus in WA
right-arrow Created with Sketch.
AL3 AML3D to investigate copper-nickel alloy printing for US Defence
right-arrow Created with Sketch.
WSR Westar uncovers historic ore in WA's Murchison grading 40g/t
right-arrow Created with Sketch.
RCE Recce Pharma picks up Chinese patent for anti-infective drugs
right-arrow Created with Sketch.
PMT Patriot sniffs pegmatite grades of 3.58% among the snows of Quebec
right-arrow Created with Sketch.
AUQ Alara Resources is driving Oman into a renewable renaissance with accelerating copper production
right-arrow Created with Sketch.

(20min delay)
Last
47.3¢ 		Change
0.013(2.72%) 		Mkt cap ! $546.8M
Open High Low Value Volume
47.0¢ 48.5¢ 47.0¢ $373.3K 786.8K

Buyers (Bids)

No. Vol. Price($)
3 93626 47.0¢
 

Sellers (Offers)

Price($) Vol. No.
47.5¢ 38412 14
View Market Depth
Last trade - 10.16am 09/05/2024 (20 minute delay) ?
Last
47.0¢ 		  Change
0.013 ( 1.51 %)
Open High Low Volume
48.0¢ 48.0¢ 47.0¢ 150459
Last updated 10.44am 09/05/2024 ?
IMM (ASX) Chart

Top Stories

Gold grading beyond 65g/t at Hillgrove gets Larvotto shares airborne

Larvotto Resources has discovered gold grading more than 65 grams per tonne at the Hillgrove project in NSW.
Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan Prominence Energy has seen shares rise 33% on news of uranium grading up to 5,269ppm from early sampling work in Kazakhstan.
Maiden drilling at West Arunta hints at major IOCG system for Rincon Rincon Resources believes that drill core picked up from a maiden program of work at its West Arunta project in Western Australia indicates potential for a major iron oxide copper gold deposit.
Alara Resources (ASX:AUQ) is driving Oman into a renewable renaissance with accelerating copper production Alara Resources has set itself up nicely in Oman to capitalise on an expected 75% surge in copper prices over the next two years.
CBA profits fall 3% in March quarter but funding portfolio is flourishing Commonwealth Bank has reported a 3 percent fall in profits for the March quarter of 2024, compared to the previous quarter.

Featured News

AUQ Alara Resources is driving Oman into a renewable renaissance with accelerating copper production
right-arrow Created with Sketch.
PMT Patriot sniffs pegmatite grades of 3.58% among the snows of Quebec
right-arrow Created with Sketch.
RCE Recce Pharma picks up Chinese patent for anti-infective drugs
right-arrow Created with Sketch.
MTL Mantle Minerals to kick off drilling at Mt Berghaus in WA
right-arrow Created with Sketch.
SBM AI helps lead the way for St Barbara to new FY25-27 production targets
right-arrow Created with Sketch.
NEWS Download the latest Thematics Insights Report: What it takes to get a new drug to market in Australia
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.